New Study Says DES Are Safer Than ThoughtNew Study Says DES Are Safer Than Thought

A study in the British journal The Lancet says that patients who receive drug-eluting stents are no more likely to die than those who receive bare-metal stents, reports the New York Times. That could temper fears about blood-clotting risks. Or maybe not. Once a negative message gets out there, it's hard to make it go away.

September 14, 2007

1 Min Read
MDDI logo in a gray background | MDDI

The study does have negative news for Boston Scientific: It says that patients with Taxus are more likely to suffer heart attacks than patients with J&J's Cypher. It also says that Taxus patients are slightly more likely to get blood clots than patients with Cypher or bare-metal stents.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like